AXANTON Trademark

Trademark Overview

On Tuesday, September 25, 2012, a trademark application was filed for AXANTON with the United States Patent and Trademark Office. The USPTO has given the AXANTON trademark a serial number of 79130267. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, September 25, 2022. The AXANTON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary products, namely, pharmaceutical products and veterinary products for prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity; dietetic food and substances, namely, foodstuffs adapted for use in the prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity; food supplements for humans and animals; chemical preparations for medical or pharmaceutical use, namely, for use in the prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity
axanton

General Information

Serial Number79130267
Word MarkAXANTON
Filing DateTuesday, September 25, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, September 25, 2022
Registration Number4541099
Registration DateTuesday, June 3, 2014
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements

Description of MarkThe mark consists of the wording "AXANTON" in stylized font.
Goods and ServicesPharmaceutical and veterinary products, namely, pharmaceutical products and veterinary products for prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity; dietetic food and substances, namely, foodstuffs adapted for use in the prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity; food supplements for humans and animals; chemical preparations for medical or pharmaceutical use, namely, for use in the prevention and treatment of infections and metabolic diseases associated with aging, or boosting immunity
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressCH
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressCH
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressCH

Trademark Events

Event DateEvent Description
Monday, April 24, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, April 24, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 20, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 18, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 18, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, June 3, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, June 13, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 28, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 23, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 23, 2014FINAL DISPOSITION PROCESSED
Wednesday, September 3, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 3, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Friday, March 14, 2014NOTIFICATION PROCESSED BY IB
Wednesday, February 26, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 26, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 13, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 13, 2014ASSIGNED TO LIE
Saturday, January 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 17, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 16, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 22, 2013REFUSAL PROCESSED BY IB
Saturday, June 29, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 29, 2013REFUSAL PROCESSED BY MPU
Wednesday, June 26, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 25, 2013NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2013NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, June 19, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 18, 2013NON-FINAL ACTION WRITTEN
Tuesday, June 11, 2013APPLICATION FILING RECEIPT MAILED
Friday, June 7, 2013ASSIGNED TO EXAMINER
Friday, June 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

axanton associated diseases aging pharmaceutical immunity metabolic boosting products infections namely